Keywords: roche, sales, ahead, profit, growth, expected, swiss
Roche's Sales Ahead, Profit Growth Expected
Article | 23 January 1995
Swiss pharmaceutical group Roche has announced sales for 1994 of 14.7 billion Swiss francs ($11.4 billion), advancing 3% in Swiss franc terms. When expressed ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
